![Intensive care medicine / Hypertension / Neurotransmitters / Nitric oxide / Nitrogen metabolism / Pulmonary hypertension / Extracorporeal membrane oxygenation / Respiratory system / Bronchopulmonary dysplasia / Medicine / Chemistry / Health Intensive care medicine / Hypertension / Neurotransmitters / Nitric oxide / Nitrogen metabolism / Pulmonary hypertension / Extracorporeal membrane oxygenation / Respiratory system / Bronchopulmonary dysplasia / Medicine / Chemistry / Health](https://www.pdfsearch.io/img/9f8bc1bff44364d2ecc5bc8f3cc21227.jpg) Date: 2011-06-28 11:53:07Intensive care medicine Hypertension Neurotransmitters Nitric oxide Nitrogen metabolism Pulmonary hypertension Extracorporeal membrane oxygenation Respiratory system Bronchopulmonary dysplasia Medicine Chemistry Health | | FOR IMMEDIATE RELEASE FDA EXTENDS MARKETING EXCLUSIVITY FOR INOMAX® Clinton, NJ, January 5, 2011– Ikaria, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted INOMAX® (nitric oxide) for i
Document is deleted from original location. Use the Download Button below to download from the Web Archive.Download Document from Web Archive File Size: 65,53 KB
|